vs
Foghorn Therapeutics Inc.（FHTX）与SWK Holdings Corp（SWKH）财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是SWK Holdings Corp的1.1倍（$9.2M vs $8.7M），Foghorn Therapeutics Inc.同比增速更快（223.8% vs -29.7%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs -12.5%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
SWK Holdings Corp是一家专注于医疗健康与生命科学领域的专业金融企业，为生物技术、制药、医疗器械及诊断类企业提供特许权使用费货币化、结构性债务、资产支持贷款等定制化融资服务，核心市场以北美地区为主。
FHTX vs SWKH — 直观对比
营收规模更大
FHTX
是对方的1.1倍
$8.7M
营收增速更快
FHTX
高出253.5%
-29.7%
两年增速更快
FHTX
近两年复合增速
-12.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $8.7M |
| 净利润 | $-21.7M | $-19.4M |
| 毛利率 | — | — |
| 营业利润率 | -258.2% | 9.9% |
| 净利率 | -234.3% | — |
| 营收同比 | 223.8% | -29.7% |
| 净利润同比 | -11.1% | -430.2% |
| 每股收益（稀释后） | $-0.35 | $-1.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXSWKH
| Q4 25 | $9.2M | $8.7M | ||
| Q3 25 | $8.2M | $10.9M | ||
| Q2 25 | $7.6M | $10.1M | ||
| Q1 25 | $6.0M | $11.8M | ||
| Q4 24 | $2.9M | $12.4M | ||
| Q3 24 | $7.8M | $10.4M | ||
| Q2 24 | $6.9M | $10.8M | ||
| Q1 24 | $5.0M | $11.4M |
净利润FHTXSWKH
| Q4 25 | $-21.7M | $-19.4M | ||
| Q3 25 | $-15.8M | $8.8M | ||
| Q2 25 | $-17.9M | $3.5M | ||
| Q1 25 | $-18.8M | $4.5M | ||
| Q4 24 | $-19.5M | $5.9M | ||
| Q3 24 | $-19.1M | $3.5M | ||
| Q2 24 | $-23.0M | $3.7M | ||
| Q1 24 | $-25.0M | $468.0K |
营业利润率FHTXSWKH
| Q4 25 | -258.2% | 9.9% | ||
| Q3 25 | -226.9% | 61.3% | ||
| Q2 25 | -279.2% | 46.1% | ||
| Q1 25 | -385.0% | 68.6% | ||
| Q4 24 | -840.5% | 44.7% | ||
| Q3 24 | -305.5% | 39.2% | ||
| Q2 24 | -386.6% | 8.3% | ||
| Q1 24 | -558.3% | 9.5% |
净利率FHTXSWKH
| Q4 25 | -234.3% | — | ||
| Q3 25 | -194.4% | 80.7% | ||
| Q2 25 | -237.3% | 35.2% | ||
| Q1 25 | -316.4% | 38.4% | ||
| Q4 24 | -682.9% | 47.5% | ||
| Q3 24 | -244.9% | 33.3% | ||
| Q2 24 | -333.6% | 33.9% | ||
| Q1 24 | -495.4% | 4.1% |
每股收益（稀释后）FHTXSWKH
| Q4 25 | $-0.35 | $-1.59 | ||
| Q3 25 | $-0.25 | $0.72 | ||
| Q2 25 | $-0.28 | $0.29 | ||
| Q1 25 | $-0.30 | $0.37 | ||
| Q4 24 | $-0.23 | $0.47 | ||
| Q3 24 | $-0.31 | $0.28 | ||
| Q2 24 | $-0.45 | $0.30 | ||
| Q1 24 | $-0.59 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | $42.8M |
| 总债务越低越好 | — | $33.0M |
| 股东权益账面价值 | $-108.5M | $235.1M |
| 总资产 | $198.1M | $272.4M |
| 负债/权益比越低杠杆越低 | — | 0.14× |
8季度趋势，按日历期对齐
现金及短期投资FHTXSWKH
| Q4 25 | $80.9M | $42.8M | ||
| Q3 25 | $89.3M | $10.2M | ||
| Q2 25 | $72.6M | $8.0M | ||
| Q1 25 | $61.0M | $29.8M | ||
| Q4 24 | $55.5M | $5.9M | ||
| Q3 24 | $57.7M | $17.2M | ||
| Q2 24 | $138.9M | $5.5M | ||
| Q1 24 | $79.3M | $5.5M |
总债务FHTXSWKH
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
股东权益FHTXSWKH
| Q4 25 | $-108.5M | $235.1M | ||
| Q3 25 | $-89.7M | $254.2M | ||
| Q2 25 | $-76.7M | $246.5M | ||
| Q1 25 | $-61.7M | $292.7M | ||
| Q4 24 | $-45.5M | $288.7M | ||
| Q3 24 | $-28.3M | $283.4M | ||
| Q2 24 | $-14.3M | $282.8M | ||
| Q1 24 | $-97.5M | $279.9M |
总资产FHTXSWKH
| Q4 25 | $198.1M | $272.4M | ||
| Q3 25 | $205.0M | $289.4M | ||
| Q2 25 | $226.2M | $285.7M | ||
| Q1 25 | $258.7M | $331.3M | ||
| Q4 24 | $284.0M | $332.2M | ||
| Q3 24 | $308.4M | $321.3M | ||
| Q2 24 | $328.6M | $321.0M | ||
| Q1 24 | $255.0M | $322.0M |
负债/权益比FHTXSWKH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $27.3M |
| 自由现金流经营现金流 - 资本支出 | — | $26.8M |
| 自由现金流率自由现金流/营收 | — | 308.1% |
| 资本支出强度资本支出/营收 | 0.0% | 5.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $43.2M |
8季度趋势，按日历期对齐
经营现金流FHTXSWKH
| Q4 25 | $-22.3M | $27.3M | ||
| Q3 25 | $-18.9M | $906.0K | ||
| Q2 25 | $-21.0M | $7.8M | ||
| Q1 25 | $-24.0M | $8.3M | ||
| Q4 24 | $-24.5M | $23.0M | ||
| Q3 24 | $-21.0M | $6.3M | ||
| Q2 24 | $-25.5M | $5.4M | ||
| Q1 24 | $-29.3M | $4.4M |
自由现金流FHTXSWKH
| Q4 25 | — | $26.8M | ||
| Q3 25 | — | $557.0K | ||
| Q2 25 | $-21.0M | $7.7M | ||
| Q1 25 | $-24.0M | $8.2M | ||
| Q4 24 | $-25.0M | $22.9M | ||
| Q3 24 | $-21.3M | $6.3M | ||
| Q2 24 | $-25.6M | $5.4M | ||
| Q1 24 | $-29.4M | — |
自由现金流率FHTXSWKH
| Q4 25 | — | 308.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | -278.2% | 77.0% | ||
| Q1 25 | -403.2% | 69.1% | ||
| Q4 24 | -875.3% | 185.3% | ||
| Q3 24 | -273.0% | 60.4% | ||
| Q2 24 | -371.0% | 49.7% | ||
| Q1 24 | -583.1% | — |
资本支出强度FHTXSWKH
| Q4 25 | 0.0% | 5.9% | ||
| Q3 25 | 0.0% | 3.2% | ||
| Q2 25 | 0.3% | 0.6% | ||
| Q1 25 | 0.5% | 0.8% | ||
| Q4 24 | 16.8% | 1.1% | ||
| Q3 24 | 4.0% | 0.3% | ||
| Q2 24 | 0.2% | 0.2% | ||
| Q1 24 | 2.0% | 0.0% |
现金转化率FHTXSWKH
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FHTX
暂无分部数据
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
